Use of prostaglandin E1 in infants with d-transposition of the great arteries and intact ventricular septum
- PMID: 88172
- DOI: 10.1016/0002-9149(79)90253-4
Use of prostaglandin E1 in infants with d-transposition of the great arteries and intact ventricular septum
Abstract
Prostaglandin E1 was used to treat five infants with d-transposition of the great arteries and intact ventricular septum who had persistent severe hypoxemia after the creation of an interatrial communication. Three infants had a dramatic improvement in systemic arterial oxygen saturation associated with dilation of the ductus arteriosus; in two of the three cases urgent surgery was avoided. Two infants had no clinical evidence of increased ductal shunting and no improvement in oxygen saturation. A trial of prostaglandin E1 is recommended for treatment of severe hypoxemia in infants with d-transposition of the great arteries with intact ventricular septum if the presence of a large atrial septal defect is established.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
